Mesenchymal Stem Cells and their Derived Exosomes Promote Malignant Phenotype of Polyploid Non-Small-Cell Lung Cancer Cells through AMPK Signaling Pathway
Chemotherapy is an important method for the treatment of non-small-cell lung cancer (NSCLC), but it can lead to side effects and polyploid cancer cells. The polyploid cancer cells can live and generate daughter cancer cells via budding. Mesenchymal stem cells (MSCs) are pluripotent stem cells with r...
Saved in:
Main Authors: | Lili Wang, Mingyue Ouyang, Sining Xing, Song Zhao, Shuo Liu, Lingyan Sun, Huiying Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2022/8708202 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes
by: June Seok Heo, et al.
Published: (2019-01-01) -
Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
by: Peter Stanko, et al.
Published: (2018-01-01) -
GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling
by: Fan Zhang, et al.
Published: (2021-01-01) -
AMPK: An energy sensor for non-small cell lung cancer progression and treatment
by: Zhi-Ting Zhong, et al.
Published: (2025-02-01) -
Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
by: Zhiping Wei, et al.
Published: (2021-01-01)